Morningstar® Stock Report™

Novartis AG NOVN

Letzte Unternehmensnews

DatumZeitQuelleTitel
Previous Stories...
16.05.202409:29DJNM*DJ Novartis Meets All Tender Offer Conditions to Acquire MorphoSys for EUR 68 Per Share in Cash
16.05.202409:27DJNMPress Release: Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash
16.05.202409:27DJNM*DJ Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash
16.05.202409:27DJNMPress Release: Novartis meets all tender offer -2-
15.05.202414:00DJNM*DJ Novartis highlights pioneering innovation in CML with data from Scemblix(R) Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
15.05.202414:00DJNMPress Release: Novartis highlights pioneering -2-
15.05.202414:00DJNMPress Release: Novartis highlights pioneering innovation in CML with data from Scemblix(R) Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
10.05.202413:42DJNMNovartis Gets FDA Breakthrough Therapy Designation for Scemblix
10.05.202413:27DJNMDJ Novartis Gets FDA Breakthrough Therapy Designation for Scemblix
10.05.202413:05DJNM*DJ Novartis: FDA Designation Was Granted Based on Positive Data From Phase 3 Study
10.05.202413:04DJNM*DJ Novartis: This Marks Third Breakthrough Therapy Designation for Scemblix
10.05.202413:03DJNM*DJ Novartis: This Is for Treatment of Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
10.05.202413:03DJNM*DJ Novartis Receives FDA Breakthrough Therapy Designation for Scemblix
02.05.202411:36DJNMNovartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business
02.05.202411:21DJNMDJ Novartis to Buy Mariana Oncology for Up to $1.75 Bln in Boost to Radioligand Therapy Business
02.05.202411:18DJNMMW Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
02.05.202411:08DJNM*DJ Novartis to Pay $1B Upfront for Mariana, Additional $750M Upon Completion of Milestones
02.05.202411:05DJNM*DJ Novartis: Acquisition Aimed at Improving Radioligand Therapy Pipeline
02.05.202411:02DJNM*DJ Novartis Enters Agreement to Acquire Mariana Oncology
30.04.202415:17DJNMPress Release: FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs